In addition, in 4G-CAR-T cell–treated mice there were lower levels of tumor-residing M2 (F4/80+ CD206+) macrophages, which are often associated with immunosuppression in the TME (Fig. 8 J, K). This evidence concerns the gene MRC1 and neoplasm.